FEASIBILITY AND SAFETY OF SIMULTANEOUSLY IMPLANTING AUTOLOGOUS REGENERATIVE PERIPHERAL NERVE TISSUE TO THE NUCLEUS BASALIS OF MEYNERT AND SUBSTANTIA NIGRA IN PATIENTS WITH PARKINSON’S DISEASE (ID 2227)

Presenter
Authors
Gallery Display
Onsite Oral and Gallery PDF

Previous ePoster
SYNAPTIC ESTROGEN RECEPTOR ALPHA IMPROVES E46K-AMPLIFIED 3K ALPHA-SYNUCLEIN NEUROPATHOLOGY AND PHENOTYPES IN MICE (ID 2225)

Next ePosters
APOLIPOPROTEIN L1 IS INCREASED IN FRONTOTEMPORAL LOBAR DEGENERATION POST-MORTEM BRAIN TISSUE BUT NOT IN CEREBROSPINAL FLUID (ID 2231)
MITOCHONDRIAL DEFECTS IN ALZHEIMER’S DISEASE: MECHANISMS AND THERAPEUTIC APPROACHES (ID 2235)
FAMILIAL ALZHEIMER'S DISEASE NEUROPROGENITOR CELLS DISPLAY PRONOUNCED MITOCHONDRIAL METABOLISM ALTERATIONS (ID 2236)
OXIDATIVE STRESS TRIGGERS BASAL FOREBRAIN NEURODEGENERATION BY IMPAIRING PRONGF AXONAL TRANSPORT (ID 2237)
INVOLVEMENT OF RNA MODIFICATIONS AND CORRESPONDING WRITER ENZYMES AT A SPECIFIC MITOCHONDRIAL MRNA SITE IN ALZHEIMER'S DISEASE (ID 2239)
NEURONS ISOLATED FROM A53T SYNUCLEIN MICE DISPLAY DEFICITS IN SYNAPTIC DENISTY AND MITOCHONDRIAL FUNCTION THAT CAN BE ATTENUATED BY NRF2 ACTIVATION (ID 2240)
THE TRANSCRIPTOMIC LANDSCAPE OF ALZHEIMER'S DISEASE REVEALS DYSREGULATED MITOCHONDRIAL-RELATED PATHWAYS (ID 2241)
LOSS OF WWOX AND MUTATIONS IN THE GENE CONTRIBUTE TO MITOCHONDRIAL DYSFUNCTION IN AMYOTROPHIC LATERAL SCLEROSIS (ID 2242)
LOAD2: A NOVEL MOUSE MODEL FOR INVESTIGATING INTERACTIONS BETWEEN GENETIC AND ENVIRONMENTAL RISK FACTORS FOR LATE-ONSET ALZHEIMER'S DISEASE (ID 2244)
SIRT6 ROLES IN PROTECTING THE BRAIN FROM NEURODEGENERATION (ID 2247)